financetom
Business
financetom
/
Business
/
Brazilian brewer Ambev's quarterly profit misses expectations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Brazilian brewer Ambev's quarterly profit misses expectations
Aug 1, 2024 12:44 AM

Aug 1 (Reuters) - Brazilian brewer Ambev ( ABEV )

reported a 5.6% decline in second-quarter net profit, just below

forecasts, although it said sales rose slightly, especially in

its home market and cost discipline measures had paid off.

The subsidiary of the world's largest brewer by volume

Belgium's Anheuser-Busch InBev posted a profit of 2.45

billion reais ($433.05 million), versus 2.50 billion real based

on analysts polled by LSEG.

While core profit was below expectations, earnings before

interest, tax, depreciation and amortisation (EBITDA) grew by

10% to 5.81 billion reais, beating a consensus forecast of 5.54

billion.

Total volumes rose 0.4%, led by Brazil and Central America

and the Caribbean, where sales of beer and non-alcoholic

beverages were resilient.

The parent company AB InBev also reported on Thursday,

beating core-profit expectations.

Analysts said the industry is returning to normality after

the disruption of the pandemic, although earlier this week

Diageo was among those to say challenges persisted because of

lingering inflationary pressures.

($1 = 5.6575 reais)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Is Confluent Stock Surging?
Why Is Confluent Stock Surging?
Oct 8, 2025
Shares of Confluent, Inc. ( CFLT ) are rising Wednesday following reports that the California-based data streaming company is considering a sale. What To Know: Reuters reported that Confluent is exploring a sale after attracting acquisition interest. The company is reportedly working with an investment bank on the sale process, which is still in the early stages. Confluent shares traded...
CervoMed Drug Cut Dementia Progression Risk By 75% In Trial
CervoMed Drug Cut Dementia Progression Risk By 75% In Trial
Oct 8, 2025
CervoMed Inc. ( CRVO ) on Wednesday shared additional data from its Phase 2b RewinD-LB trial of neflamapimod for dementia with Lewy bodies (DLB). The results are based on the final analyses of the RewinD-LB trial, conducted after the August 2025 database lock for the full 48-week trial (16 weeks placebo-controlled (Initial Phase), followed by a 32-week neflamapimod-only extension (Extension...
Pomdoctor Shares Rise in Nasdaq Debut
Pomdoctor Shares Rise in Nasdaq Debut
Oct 8, 2025
11:55 AM EDT, 10/08/2025 (MT Newswires) -- Pomdoctor (POM) shares were rising 5% in their debut on Nasdaq Wednesday after the company priced an initial public offering of about 5 million American depositary shares at $4 apiece for expected gross proceeds of $20 million. The company said the IPO is expected to close on or about Thursday. Price: 4.20, Change:...
L3Harris Technologies Wins $24 Million US Army Contract
L3Harris Technologies Wins $24 Million US Army Contract
Oct 8, 2025
11:45 AM EDT, 10/08/2025 (MT Newswires) -- L3Harris Technologies ( LHX ) won a $24 million contract from the US Army to deliver software-defined data devices aimed at enhancing battlefield communication systems. The devices are designed to support high-data throughput for the Army's Next Generation Command and Control (NGC2) network infrastructure, offering multiple, resilient transport options and ensuring interoperability across...
Copyright 2023-2026 - www.financetom.com All Rights Reserved